TRIWISE CAPITAL
TriWise Capital is an investment firm that focuses on venture capital and M&A business.
TRIWISE CAPITAL
Industry:
Finance Financial Services Venture Capital
Founded:
2015-10-01
Status:
Active
Contact:
86-0755-86912699
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Nginx Euro DigiCert SSL Pound Sterling Japanese Yen Encryption Everywhere Alibaba
Similar Organizations
Accelerate Colombia
Accelerate Colombia is an investment firm that offers venture capital for business development.
AccelHUB
AccelHUB is an investment firm that offers venture capital for business development.
CEG
CEG is an investment firm that focuses on venture capital, funding, investments and financial services for various sectors.
DGS Development
DGS Development is an institution engaged in investment in the establishment of industrial and venture capital businesses.
Global Capital Management
Global Capital Management is an investment firm that specializes in venture capital.
Haibang Capital
Haibang Capital is an investment company focusing on venture capital and private equity.
J Capital
J Capital is an investment firm primarily focused on ventures, tokens and project .
Kapor Capital
Kapor Capital is an investment firm that invests in early-stage tech-enabled startups.
Publics Venture Capital
Publics Venture Capital is an investment firm committed to cultivating and building venture capital managers into entrepreneurial investors.
TLC Capital
TLC Capital is an Atlanta-based investment firm that offers venture capital services.
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-03-07 | Qyuns Therapeutics | TriWise Capital investment in Series C - Qyuns Therapeutics | 100 M CNY |
2021-12-06 | Innoforce Pharmaceuticals | TriWise Capital investment in Series A - Innoforce Pharmaceuticals | 375 M CNY |
2021-11-23 | Triastek | TriWise Capital investment in Series B - Triastek | N/A |
2021-07-13 | Adlai Nortye | TriWise Capital investment in Series D - Adlai Nortye | 100 M USD |
2021-06-24 | Triastek | TriWise Capital investment in Series B - Triastek | 330 M CNY |
2021-06-01 | Inmagene Biopharmaceuticals | TriWise Capital investment in Series C - Inmagene Biopharmaceuticals | 100 M USD |
2020-11-11 | Asieris Pharmaceuticals | TriWise Capital investment in Series D - Asieris Pharmaceuticals | 700 M CNY |
2019-11-04 | Akeso Biopharma | TriWise Capital investment in Series D - Akeso Biopharma | 150 M USD |
2019-07-31 | Qyuns Therapeutics | TriWise Capital investment in Series B - Qyuns Therapeutics | 20 M USD |
2019-01-31 | Immvira | TriWise Capital investment in Series A - Immvira | 15 M USD |